Background: Carbamazepine is one of the most effective anticonvulsant drugs for tonic-clonic convulsions, with a daily maintenance dose of 600-1600 mg.
Materials and Methods: Over a 5-year period, from 1997to 2002, brain CT scan and/or MRI of 1832 epileptic patients with an age range of 18-70 years were reviewed. All of the patients had tonic-clonic convulsion and only used carbamazepine.
Results: Out of 1832 patients, 496 (315 males, 181females) had abnormal findings in CT and/or MRl including cerebrovascular disease, idiopathic atrophy, brain trauma, primary brain tumors, post-encephalitic findings, gliosis, brain vasculitis, idiopathic calcification, porencephaly and findings related to neurocutaneous syndromes. Effectiveness of carbamazepine in the control of symptomatic seizures were graded into 3 categories. Good; for control of seizures due to calcification, gliosis, trauma, cerebrovascular accident and idiopathic atrophy. Moderate; for control of seizures due to tumors,encephalitis, vasculitis and neurocutaneous syndromes.Poor; for control of seizures due to porencephaly.
Conclusion: About 70% of patients with abnormal findings in brain CT scan and/or MRI were controlled by carbamazepine. Carbamazepine is not a suitable drug in the control of tonic-clonic convulsions in porencephaly.